0

Chapter 19: Targeted Hormone Assessment of the Menstrual Cycle

Hilgers TW, 2004

Hilgers TW

The Medical and Surgical Practice of NaProTECHNOLOGY, 251-258, 2004

Source

Abstract

No abstract available for this article.

Topics

RRM Methods > NaProTECHNOLOGY > ProtocolRRM Methods > NaProTECHNOLOGY > Clinical OutcomesDiagnostics > Cycle Charting > MethodologyDiagnostics > Cycle Charting > Biomarker CorrelationDiagnostics > Cycle Charting > Clinical UtilityDiagnostics > Hormone Assays > ProgesteroneDiagnostics > Hormone Assays > EstrogenDiagnostics > Biomarker Monitoring > Cervical MucusReproductive Endocrinology > Ovulation > MonitoringReproductive Endocrinology > Luteal Phase > PhysiologyReproductive Endocrinology > Luteal Phase > DeficiencyReproductive Endocrinology > Progesterone > AssaysReproductive Endocrinology > Progesterone > PhysiologyReproductive Endocrinology > Estrogen > MonitoringReproductive Endocrinology > Estrogen > PhysiologyMenstrual Cycle > Physiology > Hormonal RegulationMenstrual Cycle > Physiology > Follicular PhaseMenstrual Cycle > Physiology > Luteal PhaseMenstrual Cycle > Physiology > OvulationMenstrual Cycle > Biomarkers > Cervical MucusMenstrual Cycle > Biomarkers > HormonalMenstrual Cycle > Cycle Charting > MethodsMenstrual Cycle > Cycle Charting > Clinical ApplicationInfertility > Female Factor > Ovulatory DysfunctionInfertility > Female Factor > Endometriosis-RelatedEndometriosis > Pathophysiology > BiomarkersGeneral OB/GYN > Clinical Practice > Standards

Cite this article

Hilgers, T. W. (2004). Chapter 19: Targeted Hormone Assessment of the Menstrual Cycle. *The Medical and Surgical Practice of NaProTECHNOLOGY*, 251-258.

Keywords

Hormones; Biomarkers; CrMS; CREIGHTON MODEL; NaProTECHNOLOGY; Treatment; Diagnosis; Menstrual Cycle; Fertility; Dysfunctional Uterine Bleeding; Infertility; Premenstrual Syndrome

Related articles